[Cystectomy with preservation of the prostate in the treatment of bladder tumours: anatomical basis, surgical techniques, indications and results].

Is sparing the prostate still considered radical cystectomy? The case against prostate-sparing cystectomy for bladder cancer. Can Urol Assoc J (2009) 0.75

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18

Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65

A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet (2010) 3.93

Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet (2009) 3.76

Cancer-associated regulation of alternative splicing. Nat Struct Mol Biol (2009) 3.35

Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet (2010) 2.96

The clinical research office of the endourological society ureteroscopy global study: indications, complications, and outcomes in 11,885 patients. J Endourol (2013) 2.82

Olfactory detection of prostate cancer by dogs sniffing urine: a step forward in early diagnosis. Eur Urol (2010) 2.72

FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours. Eur Urol (2008) 2.65

Identification of alternative splicing markers for breast cancer. Cancer Res (2008) 2.51

Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet (2008) 2.45

Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum. Eur Urol (2008) 2.32

Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy. Eur Urol (2011) 2.19

Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN). Eur Urol (2013) 2.18

HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet (2012) 2.18

Transcorporal artificial urinary sphincter implantation as a salvage surgical procedure for challenging cases of male stress urinary incontinence: surgical technique and functional outcomes in a contemporary series. BJU Int (2013) 2.13

TVT-O for the treatment of pure urodynamic stress incontinence: efficacy, adverse effects, and prognostic factors at 5-year follow-up. Eur Urol (2012) 2.06

Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. Eur Urol (2007) 2.04

Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol (2006) 1.90

Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. Proc Natl Acad Sci U S A (2009) 1.81

First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer. BJU Int (2014) 1.75

Flexible ureterorenoscopy with holmium laser in horseshoe kidneys. Urology (2010) 1.63

Duloxetine for mild to moderate postprostatectomy incontinence: preliminary results of a randomised, placebo-controlled trial. Eur Urol (2010) 1.56

Cough anal reflex: strict relationship between intravesical pressure and pelvic floor muscle electromyographic activity during cough. Urodynamic and electrophysiological study. J Urol (2005) 1.54

Expression of estrogen related proteins in hormone refractory prostate cancer: association with tumor progression. J Urol (2010) 1.52

Accuracy of the prostate health index versus the urinary prostate cancer antigen 3 score to predict overall and significant prostate cancer at initial biopsy. Prostate (2014) 1.48

Quantification of expression of netrins, slits and their receptors in human prostate tumors. Int J Cancer (2003) 1.45

Demographics and characterization of 10,282 Randall plaque-related kidney stones: a new epidemic? Medicine (Baltimore) (2015) 1.45

Secondary chemoprevention of localized prostate cancer by short-term androgen deprivation to select indolent tumors suitable for active surveillance: a prospective pilot phase II study. World J Urol (2013) 1.42

Prospective, multidimensional evaluation of sexual disorders in men after laser photovaporization of the prostate. J Sex Med (2013) 1.42

Prostate-sparing cystectomy for bladder cancer: a step toward a dead-end. Urology (2010) 1.41

Flexible ureteroscopy and laser lithotripsy for stones >2 cm: a systematic review and meta-analysis. J Endourol (2012) 1.40

Hereditary-like urothelial carcinomas of the upper urinary tract benefit more from adjuvant cisplatin-based chemotherapy after radical nephroureterectomy than do sporadic tumours. BJU Int (2013) 1.40

[Role of endoscopy in the management of upper urinary tract tumors]. Prog Urol (2006) 1.39

Impact on active scope deflection and irrigation flow of all endoscopic working tools during flexible ureteroscopy. Eur Urol (2004) 1.35

A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23. Hum Mol Genet (2011) 1.34

Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet (2013) 1.34

The AdVance transobturator male sling for postprostatectomy incontinence: clinical results of a prospective evaluation after a minimum follow-up of 6 months. Eur Urol (2009) 1.32

EAU guidelines on laser technologies. Eur Urol (2012) 1.27

Renal cell carcinoma of native kidney in renal transplant recipients. BJU Int (2006) 1.26

Tubulocystic carcinoma of the kidney: a new entity among renal tumors. Virchows Arch (2007) 1.25

Proteins associated with the exon junction complex also control the alternative splicing of apoptotic regulators. Mol Cell Biol (2011) 1.24

Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage. Clin Cancer Res (2007) 1.23

RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues. Mol Cell Biol (2012) 1.22

Stone-free rate (SFR): a new proposal for defining levels of SFR. Urolithiasis (2013) 1.22

Management of the complications of the synthetic slings. Curr Opin Urol (2006) 1.19

Technique and complications of transurethral surgery for bladder tumours. BJU Int (2004) 1.19

Late metastasis of renal cell carcinoma to the submaxillary gland 10 years after radical nephrectomy. Int J Urol (2006) 1.19

Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. Hum Mol Genet (2011) 1.17

Alternative splicing of SYK regulates mitosis and cell survival. Nat Struct Mol Biol (2011) 1.17

New-generation flexible ureterorenoscopes are more durable than previous ones. Urology (2006) 1.17

Body mass index and outcome of tension-free vaginal tape. Eur Urol (2003) 1.16

Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine. BJU Int (2011) 1.15

Objective and subjective cure rates after trans-obturator tape (OBTAPE) treatment of female urinary incontinence. Eur Urol (2005) 1.13

Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases. Pathology (2010) 1.13

A widespread population study of actual medical management of lower urinary tract symptoms related to benign prostatic hyperplasia across Europe and beyond official clinical guidelines. Eur Urol (2010) 1.13

Midterm prospective evaluation of TVT-Secur reveals high failure rate. Eur Urol (2010) 1.13

EAU guidelines on robotic and single-site surgery in urology. Eur Urol (2013) 1.13

Down-regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate. Prostate (2002) 1.10

Percutaneous management of staghorn calculi in horseshoe kidneys: a multi-institutional experience. J Endourol (2010) 1.10

Mid-term evaluation of the transobturator male sling for post-prostatectomy incontinence: focus on prognostic factors. BJU Int (2010) 1.09

A prospective study of sexual and urinary function before and after total mesorectal excision with autonomic nerve preservation for rectal cancer. Surgery (2002) 1.06

Association between estrogen and androgen receptor genes and prostate cancer risk. Eur J Endocrinol (2008) 1.06

PRPF mutations are associated with generalized defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa. Hum Mol Genet (2011) 1.04

Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology (2006) 1.04

MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation. Nat Commun (2013) 1.03

Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study. Cancer Res (2011) 1.03

Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria. Clin J Am Soc Nephrol (2011) 1.03

Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. Eur Urol (2006) 1.02

Methylated genes as potential biomarkers in prostate cancer. BJU Int (2010) 1.02

Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. J Pediatr Urol (2009) 1.02

Training in ureteroscopy: a critical appraisal of the literature. BJU Int (2011) 1.01

Results of the tension-free vaginal tape technique in the elderly. Eur Urol (2003) 1.00

Gene expression profiling in clinically localized prostate cancer: a four-gene expression model predicts clinical behavior. Clin Cancer Res (2003) 1.00

Outcome after radical prostatectomy in young men with or without a family history of prostate cancer. Urology (2006) 1.00

Stress incontinence injection therapy: what is best for our patients? Eur Urol (2005) 1.00

Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2. Cancer Epidemiol Biomarkers Prev (2010) 0.99

Which ureteral access sheath is compatible with your flexible ureteroscope? J Endourol (2013) 0.99

Outcomes of flexible ureterorenoscopy and laser fragmentation for renal stones: comparison between digital and conventional ureteroscope. Urology (2013) 0.99

Influence of the severity of stress urinary incontinence on quality of life, health care seeking, and treatment: A national cross-sectional survey. Eur Urol (2006) 0.99

Relationships between carbonation rate of carbapatite and morphologic characteristics of calcium phosphate stones and etiology. Urology (2009) 0.99

Laparoscopic excision of seminal vesicle cyst revealed by obstruction urinary symptoms. Int J Urol (2006) 0.98

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression. Int J Cancer (2008) 0.98

8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy. Hum Pathol (2013) 0.98